The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
BIRAC Consortium, Stahl, E. A., YEAR Consortium, Raychaudhuri, S., Remmers, E. F., Xie, G., Eyre, S., Thomson, B. P., Li, Y., Kurreeman, F. A. S., et al. (2010) · Nature Genetics · doi:10.1038/ng.582 · Cited by 1,253
Tsou, C.-L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., & Charo, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29919 · Cited by 1,152
Chemokines and Cell Migration in Secondary Lymphoid Organs
Cyster, J. G. (1999) · Science · doi:10.1126/science.286.5447.2098 · Cited by 1,031
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Balashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 849
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., & Schall, T. J. (1993) · Cell · doi:10.1016/0092-8674(93)90118-a · Cited by 763
Self-citationMaraviroc for Previously Treated Patients with R5 HIV-1 Infection
Gulick, R. M., Lalezari, J., Goodrich, J., Clumeck, N., DeJesus, E., Horban, A., Nadler, J., Clotet, B., Karlsson, A., Wohlfeiler, M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803152 · Cited by 752
The chemokine and chemokine receptor superfamilies and their molecular evolution.
Zlotnik, A., Yoshie, O., & Nomiyama, H. (2006) · Genome biology · doi:10.1186/gb-2006-7-12-243 · Cited by 604
Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
Viola, A., & Luster, A. D. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154841 · Cited by 583
Kakinuma, T., Nakamura, K., Wakugawa, M., Mitsui, H., Tada, Y., Saeki, H., Torii, H., Asahina, A., Onai, N., Matsushima, K., et al. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.113237 · Cited by 575
Migratory fate and differentiation of blood monocyte subsets
Tacke, F., & Randolph, G. J. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.025 · Cited by 528
Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1215 · Cited by 405
Self-citationPolymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
Moatti, D. (2001) · Blood · doi:10.1182/blood.v97.7.1925 · Cited by 349
Gao, J. L., Kuhns, D. B., Tiffany, H. L., McDermott, D., Li, X., Francke, U., & Murphy, P. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1421 · Cited by 342
Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis
Peters, W., Scott, H. M., Chambers, H. F., Flynn, J. L., Charo, I. F., & Ernst, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131207398 · Cited by 331
Chemokines and leukocyte traffic
Sallusto, F., & Baggiolini, M. (2008) · Nature Immunology · doi:10.1038/ni.f.214 · Cited by 325
CCL28 Has Dual Roles in Mucosal Immunity as a Chemokine with Broad-Spectrum Antimicrobial Activity
Hieshima, K., Ohtani, H., Shibano, M., Izawa, D., Nakayama, T., Kawasaki, Y., Shiba, F., Shiota, M., Katou, F., Saito, T., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1452 · Cited by 260
Haringman, J. J., Gerlag, D. M., Smeets, T. J. M., Baeten, D., van den Bosch, F., Bresnihan, B., Breedveld, F. C., Dinant, H. J., Legay, F., Gram, H., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21975 · Cited by 258
Trebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242
Vergunst, C. E., Gerlag, D. M., Lopatinskaya, L., Klareskog, L., Smith, M. D., van den Bosch, F., Dinant, H. J., Lee, Y., Wyant, T., Jacobson, E. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23591 · Cited by 236
Haringman, J. J., Smeets, T. J. M., Reinders-Blankert, P., & Tak, P. P. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037176 · Cited by 227
Haringman, J. J., Kraan, M. C., Smeets, T. J. M., Zwinderman, K. H., & Tak, P. P. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.8.715 · Cited by 217
Moving targets: cell migration inhibitors as new anti-inflammatory therapies
Mackay, C. R. (2008) · Nature Immunology · doi:10.1038/ni.f.210 · Cited by 216
Brühl, H., Cihak, J., Schneider, M. A., Plachý, J., Rupp, T., Wenzel, I., Shakarami, M., Milz, S., Ellwart, J. W., Stangassinger, M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.890 · Cited by 185
Proteolytic Activation of Alternative CCR1 Ligands in Inflammation
Berahovich, R. D., Miao, Z., Wang, Y., Premack, B., Howard, M. C., & Schall, T. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7341 · Cited by 181
Self-citationSkov, L., Beurskens, F. J., Zachariae, C. O. C., Reitamo, S., Teeling, J., Satijn, D., Knudsen, K. M., Boot, E. P. J., Hudson, D., Baadsgaard, O., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.669 · Cited by 177
Determining the Potency and Molecular Mechanism of Action of Insurmountable Antagonists
Kenakin, T., Jenkinson, S., & Watson, C. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107375 · Cited by 174
Therapeutic antibodies directed at G protein-coupled receptors
Hutchings, C. J., Koglin, M., & Marshall, F. H. (2010) · mAbs · doi:10.4161/mabs.2.6.13420 · Cited by 169
Kraan, M. C., Reece, R. J., Barg, E. C., Smeets, T. J. M., Farnell, J., Rosenburg, R., Veale, D. J., Breedveld, F. C., Emery, P., & Tak, P. P. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1820::aid-anr18>3.0.co;2-d · Cited by 166
Walters, M. J., Wang, Y., Lai, N., Baumgart, T., Zhao, B. N., Dairaghi, D. J., Bekker, P. J., Ertl, L. S., Penfold, M. E. T., Jaén, J. C., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169714 · Cited by 161
Self-citationRichardson, R. M., Marjoram, R. J., Barak, L. S., & D, R. S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2904 · Cited by 159
The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC
Bardi, G., Lipp, M., Baggiolini, M., & Loetscher, P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3291::aid-immu3291>3.0.co;2-z · Cited by 147
Quinones, M. P., Ahuja, S. K., Jiménez, F., Schaefer, J., Garavito, É., Rao, A., Chenaux, G., Reddick, R. L., Kuziel, W. A., & Ahuja, S. S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420126 · Cited by 147
CC Chemokine Receptor-3 Undergoes Prolonged Ligand-induced Internalization
Zimmermann, N., Conkright, J. J., & Rothenberg, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12611 · Cited by 130
Chemokines and asthma: redundancy of function or a coordinated effort?
Lukacs, N. W., Oliveira, S. H. P., & Hogaboam, C. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8125 · Cited by 110
Anti-chemokine small molecule drugs: a promising future?
Proudfoot, A. E. J., Power, C., & Schwarz, M. K. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903535867 · Cited by 109
Self-citationStruthers, M. D., & Pasternak, A. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791561255 · Cited by 93
CCR1 Antagonists: What Have We Learned From Clinical Trials
Gladue, R. P., Brown, M. F., & Zwillich, S. H. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791561237 · Cited by 92
Computer modeling of promoter organization as a tool to study transcriptional coregulation
Werner, T. B., Fessele, S., Maier, H., & Nelson, P. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0955rev · Cited by 88
Vergunst, C. E., Gerlag, D. M., Moltke, L. L. V., Karol, M. D., Wyant, T. L., Chi, X., Matzkin, E., Leach, T. S., & Tak, P. P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24978 · Cited by 81
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial
van Kuijk, A. W. R., Vergunst, C. E., Gerlag, D. M., Bresnihan, B., Gómez-Reino, J. J., Rouzier, R., Verschueren, P., van der Leij, C., Maas, M. M., Kraan, M. C., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131235 · Cited by 70
Gerlag, D. M., Hollis, S., Layton, M., Vencovský, J., Szekanecz, Z., Braddock, M., Tak, P. P., & ESCAPE Study Group (2010) · Arthritis & Rheumatism · doi:10.1002/art.27652 · Cited by 68
Knock out models to dissect chemokine receptor function in vivo
Power, C. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00419-2 · Cited by 64
Dairaghi, D. J., Zhang, P., Wang, Y., Seitz, L. C., Johnson, D. A., Miao, S., Ertl, L. S., Zeng, Y., Powers, J. P., Pennell, A. M. K., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.33 · Cited by 58
Self-citationCCR9 and inflammatory bowel disease
Koenecke, C., & Förster, R. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902762928 · Cited by 55
Zheng, X., Nakamura, K., Furukawa, H., Nishibu, A., Takahashi, M., Tojo, M., Kaneko, F., Kakinuma, T., & Tamaki, K. (2003) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2003.tb00329.x · Cited by 51
CCR5 is involved in resolution of inflammation in proteoglycan‐induced arthritis
Doodes, P. D., Cao, Y., Hamel, K. M., Wang, Y., Rodeghero, R., Kobezda, T., & Finnegan, A. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24842 · Cited by 50
Watarai, Y., Koga, S., Paolone, D. R., Engeman, T. M., Tannenbaum, C. S., Hamilton, T. A., & Fairchild, R. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.6027 · Cited by 47
Understanding selective trafficking of lymphocyte subsets
Heydtmann, M., & Adams, D. H. (2002) · Gut · doi:10.1136/gut.50.2.150 · Cited by 25
Keshav, S., Johnson, D., Bekker, P. J., & Schall, T. J. (2009) · Gastroenterology · doi:10.1016/s0016-5085(09)60295-x · Cited by 21
Self-citationElsner, J., Dulkys, Y., Kimmig, D., et al. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000053719 · Cited by 10
Cited by
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Neutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationMast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Metadata
- Authors
- Schall, T. J., & Proudfoot, A. E. I.
- Venue
- Nature Reviews Immunology
- Published
- 2011-04-15
- Volume
- 11
- Issue
- 5
- Pages
- 355-363
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2002489008
- Cited by
- 318
- References
- 57
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.